In 2015, the National Heart Foundation of Australia (NHFA) and the Cardiac Society of Australia and New Zealand (CSANZ) undertook a survey of emerging issues in cardiovascular disease. The goal was to prioritise clinical conditions that would benefit from locally developed contemporary guidelines. Individual diseases were evaluated according to burden of disease, the existence of treatment gaps, an evolving therapeutic landscape, evidence of inequity and the existence of local treatment guidelines. Atrial fibrillation (AF) scored highly in each of these categories. Specifically, AF was recognised as a burdensome condition with increasing prevalence, where large numbers of patients are not treated with anticoagulation, despite the clear benefit of this therapy in stroke prevention.
Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
This is a human-readable summary of (and not a substitute for) the license. Disclaimer You are free to:
Share — copy and redistribute the material in any medium or format
The licensor cannot revoke these freedoms as long as you follow the license terms.
- Atrial Fibrillation
- National Heart Foundation -Australia